The Full Wiki

More info on Esreboxetine

Esreboxetine: Wikis

Advertisements

Note: Many of our articles have direct quotes from sources you can cite, within the Wikipedia article! This article doesn't yet, but we're working on it! See more info or our list of citable articles.

Encyclopedia

From Wikipedia, the free encyclopedia

Esreboxetine
Systematic (IUPAC) name
(2S)-2-[(S)-(2-ethoxyphenoxy)phenylmethyl]morpholine
Identifiers
CAS number 98819-76-2
ATC code none
Chemical data
Formula C19H23NO3 
Mol. mass 313.391 g/mol
Therapeutic considerations
Pregnancy cat.  ?
Legal status Uncontrolled
Routes Oral

Esreboxetine is a selective norepinephrine reuptake inhibitor which was under development by Pfizer for the treatment of neuropathic pain and fibromyalgia but failed to show significant benefit over currently available medications and was discontinued.[1][2][3][4] It is the (+)-(S,S)-enantiomer of reboxetine and is even more selective in comparison.[1][5]

See also

References

  1. ^ a b Matilda Bingham; Napier, Susan Jolliffe (2009). Transporters as Targets for Drugs (Topics in Medicinal Chemistry). Berlin: Springer. ISBN 3-540-87911-0. http://books.google.com/books?id=u5nVEyVchwUC&lpg=PA81&dq=esreboxetine&pg=PA81#v=onepage&q=&f=false. 
  2. ^ Rao SG (October 2009). "Current progress in the pharmacological therapy of fibromyalgia". Expert Opinion on Investigational Drugs 18 (10): 1479–93. doi:10.1517/13543780903203771. PMID 19732029. http://informahealthcare.com/doi/abs/10.1517/13543780903203771. 
  3. ^ "Search of: esreboxetine - List Results - ClinicalTrials.gov". http://clinicaltrials.gov/ct2/results?term=esreboxetine. 
  4. ^ "Musculoskeletal Report: Pfizer Stops Work on Esreboxetine for FM". http://www.mskreport.com/articles.cfm?articleID=3293. 
  5. ^ Fish, P. V.; MacKenny, M.; Bish, G.; Buxton, T.; Cave, R.; Drouard, D.; Hoople, D.; Jessiman, A. et al. (2009). "Enantioselective synthesis of (R)- and (S)-N-Boc-morpholine-2-carboxylic acids by enzyme-catalyzed kinetic resolution: application to the synthesis of reboxetine analogs". Tetrahedron Letters 50: 389. doi:10.1016/j.tetlet.2008.11.025.  edit
Advertisements

Advertisements






Got something to say? Make a comment.
Your name
Your email address
Message